Nicole Bozza

Expanding the Arsenal of FGFR Inhibitors: A Novel Chloroacetamide Derivative as a New Irreversible Agent With Anti-proliferative Activity Against FGFR1-Amplified Lung Cancer Cell Lines

Claudia Fumarola, Nicole Bozza, Riccardo Castelli et al. · Frontiers in Oncology · 2019 · 46 citations · Full text

A sulfonyl fluoride derivative inhibits EGFRL858R/T790M/C797S by covalent modification of the catalytic lysine

Francesca Ferlenghi, Laura Scalvini, Federica Vacondio et al. · European Journal of Medicinal Chemistry · 2021 · 46 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Biochemistry +9

Synthesis, Structural Elucidation, and Biological Evaluation of NSC12, an Orally Available Fibroblast Growth Factor (FGF) Ligand Trap for the Treatment of FGF-Dependent Lung Tumors

Riccardo Castelli, Arianna Giacomini, Mattia Anselmi et al. · Journal of Medicinal Chemistry · 2016 · 34 citations · Full text

Fgf2/fgfr Interaction, Fgf Trap Molecule, Chemical Biology +26

Balancing reactivity and antitumor activity: heteroarylthioacetamide derivatives as potent and time-dependent inhibitors of EGFR

Riccardo Castelli, Nicole Bozza, Andrea Cavazzoni et al. · European Journal of Medicinal Chemistry · 2018 · 15 citations · Full text

Medicinal Chemistry, Antitumor Activity, Time-dependent Inhibitors +9

Halting the FGF/FGFR axis leads to antitumor activity in Waldenström macroglobulinemia by silencing MYD88

Antonio Sacco, Cinzia Federico, Arianna Giacomini et al. · Blood · 2020 · 15 citations · Full text